The immunostimulant RU41740 from Klebsiella pneumoniae activates human cells in whole blood to potentially stimulate innate and adaptive immune responses

International Immunopharmacology
Sigifredo Pedraza-SánchezLakshmi Ramachandra

Abstract

The compound RU41740 from Klebsiella pneumoniae, when used as an immunostimulant, improves responses to bacterial and yeast infections in murine models and in human trials. The aim of this study was to determine in vitro, the capacity of RU41740 to stimulate human leukocytes in whole blood. Blood samples from healthy adult donors were incubated with RU41740 for 4 or 24 h and leukocytes were assessed for levels of activation markers and cytokine production by flow cytometry and ELISA. The early activation marker CD69 was induced at 4 h in NK cells > B cells > T cells > monocytes whereas at 24 h CD80 and CD86 levels were augmented on monocytes and IL-12 was induced; HLA-DR levels increased on both B cells and monocytes. The pro-inflammatory cytokines TNF-alpha and IL-6 were produced at 4 h at similar levels to that induced by LPS and monocytes appeared to be a source of TNF-alpha. IFN-gamma, was induced at 5 h just in NK cells. Activation induced by RU41740 was not abolished by polymixin B, ruling out the possible contamination with LPS. These data indicate that RU41740 can impact not only the innate immune responses but potentially enhance adaptive immune responses by up-regulating expression of molecules involved in antigen pre...Continue Reading

References

Jan 1, 1989·International Journal of Immunopharmacology·G MiglioratiC Riccardi
Jan 1, 1988·Respiration; International Review of Thoracic Diseases·A FiettaG G Grassi
Jan 1, 1988·International Journal of Immunopharmacology·A DurandyC Griscelli
Jan 1, 1986·International Journal of Immunopharmacology·J P AndreuxP Smets
Jan 1, 1986·International Journal of Immunopharmacology·S SozzaniF Spreafico
Sep 1, 1994·Stem Cells·S F ZieglerM R Alderson
Mar 22, 2002·Nature Reviews. Immunology·R Medzhitov
Apr 3, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Suwannee UthaisangsookSoichi Haraguchi
Dec 24, 2002·Current Opinion in Immunology·Shizuo Akira
Aug 6, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jeremy Bradshaw
Nov 13, 2003·Journal of Ethnopharmacology·V LakshmiK C Saxena
Jun 29, 2004·Journal of Virology·Mimi Guebre-XabierGregory M Glenn
Jul 13, 2004·Vaccine·Radek SpisekJirina Bartunkova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.